Urethral condyloma acuminata in a male patient refractory to common topical treatments: A case report

Refractory urethral condyloma acuminata

Authors

  • Devi Artami Susetiati Department of Dermatology and Venereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada
  • Niken Trisnowati Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Indonesia
  • Yohanes Ridora Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Indonesia

DOI:

https://doi.org/10.66344/jpad.v31i4.1729

Abstract

Condyloma acuminata is one of the most prevalent sexually transmitted diseases caused by human papilloma virus (HPV). Urethral involvement of condyloma acuminata is uncommon and more challenging to treat. Despite more condylomas are associated with the low-risk HPV (e.g., types 6 and 11), histopathologic examination is sometimes needed to exclude malignant process, especially in a lesion with atypical form or unresponsive to the standard therapy. Here we report a unique case of urethral condyloma acuminata in a male patient that refractory to the common condyloma topical treatments.

References

1. Timm B, Connor T, Liodakis P, Jayarajan J. Pan-urethral condylomata acuminata – A primary treatment recommendation based on our experience. Urol Case Reports.2020; 31(February):101149.

2. Florin HJ, Snoeck R, Van Cleynenbreugel B, Albersen M. Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature. Antiviral Res.2018;158:238–43.

3. Meliti A, Hawari A, Al-maghrabi H, Mokhtar G. Condyloma accuminatum of the male urethra : A case report. SAGE Open Med Case Rep.2020;8:2050313X20904584.

4. Grce M, Mravak-Stipetić M. Human papillomavirus-associated diseases. Clin Dermatol.2014;32(2):253–8.

5. Vives Á, Vazquez A, Rajmil O, Cosentino M. Urethral condylomas in men: experience in 123 patients without previous treatment. Int J STD AIDS.2016;27(1):39–43.

6. Debenedictis TJ, Marmar JL, Praiss DE. Intraurethral condylomas acuminta: management and review of the literature. J Urol.1977;118(5):767–9.

7. Kleiman H, Lancaster Y. Condyloma acuminata of the bladder. J Urol.1962;88(1):52–5.

8. Chabchoub I, Rabhi F, Youssef S, Jaber K, Dhaoui MA. Penile intraepithelial neoplasia developed on HPV-6 urethral condyloma. Press Medicale.2019;48(9):1001–2.

9. Dadar M, Chakraborty S, Dhama K, Prasad M, Khandia R, Hassan S, et al. Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus. Front Immunol.2018;9:2478.

10. Graversen PH, Bagi P, Rosenkilde P. Laser treatment of recurrent urethral condylomata acuminata in men. Scand J Urol Nephrol.1990;24(3):163–6.

11. Dretler SP, Klein LA. The eradication of intraurethral condyloma acuminata with 5 per cent 5 fluorouracil cream. J Urol.1975;113(2):195–8.

12. Huang J, Zeng Q, Zuo C, Yang S, Xiang Y, Lu J, et al. The combination of CO2 laser vaporation and photodynamic therapy in treatment of condylomata acuminata. Photodiagnosis Photodyn Ther.2014; 11(2):130–3.

13. Shan X, Wang N, Li Z, Hou J, Zheng R, Tian H, et al. An open uncontrolled trial of topical 5-aminolevulinic acid photodynamic therapy for the treatment of urethral condylomata acuminata in male patients. Indian J Dermatol Venereol Leprol.2016; 82(1):65–7.

Downloads

Published

29.03.2022

How to Cite

1.
Urethral condyloma acuminata in a male patient refractory to common topical treatments: A case report: Refractory urethral condyloma acuminata. J Pak Assoc Dermatol [Internet]. 2022 Mar. 29 [cited 2026 Sep. 18];31(4):763-6. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1729